salicylic acid has been researched along with capecitabine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Beckford, A; Demierre, MF; Goldberg, L; Jalisi, S; Lerner, A; Ugent, S | 1 |
| Aiba, S; Fujimura, T; Haga, T; Hashimoto, A; Hidaka, T; Mizuashi, M; Onami, K; Watabe, A | 1 |
| Ha, JY; Hwang, IG; Jung, MK; Kim, JT; Oh, EH; Park, SE | 1 |
4 other study(ies) available for salicylic acid and capecitabine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment.
Topics: Acrospiroma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Male; Remission Induction; Scalp; Sweat Gland Neoplasms | 2011 |
Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Capecitabine; Carcinoma; Deoxycytidine; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lapatinib; Liver Neoplasms; Male; Middle Aged; Quinazolines; Receptor, ErbB-2; Scalp; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Choroidal and skin metastases from colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Biopsy; Capecitabine; Choroid Neoplasms; Colorectal Neoplasms; Disease Progression; Drug Administration Schedule; Fatal Outcome; Female; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Scalp; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2016 |